
By: Einer Elhauge (ProMarket)
The head of the Department of Justice’s Antitrust Division, Jonathan Kanter, made a recent speech adopting the Neo-Brandiesian position that in antitrust cases the consumer welfare standard should be jettisoned and replaced with a “competition and the competitive process” test. I quite agree with him and the Neo-Brandiesians that the way that courts have applied the consumer welfare standard has led to uncertainty and underenforcement. But I think his approach raises serious concerns of legal theory and strategy.
Concerns of Legal Theory
Kanter is right that antitrust law protects “competition and the competitive process”.[1] But the consumer welfare standard was never an alternative to that legal test. It was only a method to resolve deep ambiguities about what “competition and the competitive process” means, and Kanter offers no alternative to resolve them.
To take a simple concrete case, suppose a merger between two firms in a ten-firm market makes the merged firm a more efficient and vigorous competitor. Does that decrease “competition” because it eliminates one competitor or increase it because we now have more vigorous competition among the nine that remain? Nothing in the “competition and the competitive process” test helps provide an answer…
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas